Trulieve Cannabis Analyst Ratings
Trulieve Cannabis Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/11/2023 | 44.92% | Wedbush | $8 → $6 | Maintains | Outperform |
08/10/2023 | 117.39% | Needham | $10 → $9 | Maintains | Buy |
05/10/2023 | 141.54% | Needham | $12 → $10 | Maintains | Buy |
03/09/2023 | 189.85% | Needham | $14.25 → $12 | Maintains | Buy |
03/09/2023 | 793.7% | Cantor Fitzgerald | $41 → $37 | Maintains | Overweight |
03/06/2023 | 890.31% | Cantor Fitzgerald | $51 → $41 | Maintains | Overweight |
12/02/2022 | 334.77% | Wedbush | → $18 | Initiates Coverage On | → Outperform |
11/10/2022 | 1131.85% | Cantor Fitzgerald | $54 → $51 | Maintains | Overweight |
08/11/2022 | 1204.32% | Cantor Fitzgerald | $57 → $54 | Maintains | Overweight |
07/22/2022 | 455.54% | Seaport Global | → $23 | Initiates Coverage On | → Buy |
05/13/2022 | 1276.78% | Cantor Fitzgerald | $59 → $57 | Maintains | Overweight |
03/31/2022 | 1035.24% | Needham | $50 → $47 | Maintains | Buy |
03/29/2022 | 1349.24% | Cantor Fitzgerald | $72 → $60 | Maintains | Overweight |
02/18/2022 | 1107.7% | Needham | $54 → $50 | Maintains | Buy |
01/07/2022 | — | Wolfe Research | Initiates Coverage On | → Outperform | |
12/06/2021 | 1639.09% | Cantor Fitzgerald | $73 → $72 | Maintains | Overweight |
11/03/2021 | 1663.24% | Cantor Fitzgerald | $77 → $73 | Maintains | Overweight |
09/22/2021 | 1856.47% | Cantor Fitzgerald | $50.5 → $81 | Maintains | Overweight |
08/05/2021 | 1548.51% | Needham | $62.25 → $68.25 | Maintains | Buy |
07/07/2021 | 1397.55% | Jefferies | → $62 | Initiates Coverage On | → Buy |
05/14/2021 | 1614.93% | Cantor Fitzgerald | $76 → $71 | Maintains | Overweight |
05/10/2021 | 1735.7% | Cantor Fitzgerald | $89 → $76 | Maintains | Overweight |
04/30/2021 | 2049.71% | Cantor Fitzgerald | $83 → $89 | Maintains | Overweight |
03/24/2021 | 1367.36% | Needham | $60.5 → $60.75 | Maintains | Buy |
02/04/2021 | 1349.24% | Roth Capital | → $60 | Initiates Coverage On | → Buy |
11/17/2020 | 1421.7% | Cantor Fitzgerald | $60 → $63 | Maintains | Overweight |
09/17/2020 | 1349.24% | Cantor Fitzgerald | $59 → $60 | Maintains | Overweight |
08/04/2020 | 606.5% | Needham | $18.2 → $29.25 | Maintains | Buy |
06/30/2020 | 1156.01% | Cantor Fitzgerald | $50 → $52 | Maintains | Overweight |
05/21/2020 | 339.6% | Needham | $17.2 → $18.2 | Maintains | Buy |
05/13/2020 | 315.45% | Needham | $15.5 → $17.2 | Maintains | Buy |
04/09/2020 | 274.39% | Needham | $15.25 → $15.5 | Maintains | Buy |
04/06/2020 | 624.62% | Cantor Fitzgerald | $32 → $30 | Maintains | Overweight |
03/23/2020 | 268.35% | Needham | $20 → $15.25 | Maintains | Buy |
02/14/2020 | 624.62% | Cantor Fitzgerald | → $30 | Initiates Coverage On | → Overweight |
12/16/2019 | 383.08% | Craig-Hallum | → $20 | Initiates Coverage On | → Buy |
12/03/2019 | 383.08% | Needham | → $20 | Initiates Coverage On | → Buy |
12/02/2019 | 310.62% | Compass Point | $11 → $17 | Upgrades | Neutral → Buy |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
2023年08月11日 | 44.92% | 韋德布什 | $8→$6 | 維護 | 跑贏大盤 |
2023年08月10日 | 117.39% | 李約瑟 | $10→$9 | 維護 | 買 |
2023年05月10日 | 141.54% | 李約瑟 | $12→$10 | 維護 | 買 |
03/09/2023 | 189.85% | 李約瑟 | $14.25→$12 | 維護 | 買 |
03/09/2023 | 793.7% | 康託·菲茨傑拉德 | $41→$37 | 維護 | 超重 |
03/06/2023 | 890.31% | 康託·菲茨傑拉德 | $51→$41 | 維護 | 超重 |
12/02/2022 | 334.77% | 韋德布什 | →$18 | 開始承保 | →跑贏大盤 |
2022年11月10日 | 1131.85% | 康託·菲茨傑拉德 | $54→$51 | 維護 | 超重 |
2022年08月11日 | 1204.32% | 康託·菲茨傑拉德 | $57→$54 | 維護 | 超重 |
07/22/2022 | 455.54% | 環球海港 | →$23 | 開始承保 | →購買 |
2022年05月13日 | 1276.78% | 康託·菲茨傑拉德 | $59→$57 | 維護 | 超重 |
03/31/2022 | 1035.24% | 李約瑟 | $50→$47 | 維護 | 買 |
03/29/2022 | 1349.24% | 康託·菲茨傑拉德 | $72→$60 | 維護 | 超重 |
02/18/2022 | 1107.7% | 李約瑟 | $54→$50 | 維護 | 買 |
01/07/2022 | - | 沃爾夫研究 | 開始承保 | →跑贏大盤 | |
12/06/2021 | 1639.09% | 康託·菲茨傑拉德 | $73→$72 | 維護 | 超重 |
11/03/2021 | 1663.24% | 康託·菲茨傑拉德 | $77→$73 | 維護 | 超重 |
09/22/2021 | 1856.47% | 康託·菲茨傑拉德 | $50.5→$81 | 維護 | 超重 |
08/05/2021 | 1548.51% | 李約瑟 | $62.25→$68.25 | 維護 | 買 |
07/07/2021 | 1397.55% | 傑富瑞 | →$62 | 開始承保 | →購買 |
2021/05/14 | 1614.93% | 康託·菲茨傑拉德 | $76→$71 | 維護 | 超重 |
2021/05/10 | 1735.7% | 康託·菲茨傑拉德 | $89→$76 | 維護 | 超重 |
04/30/2021 | 2049.71% | 康託·菲茨傑拉德 | $83→$89 | 維護 | 超重 |
03/24/2021 | 1367.36% | 李約瑟 | $60.5→$60.75 | 維護 | 買 |
02/04/2021 | 1349.24% | 羅斯資本 | →$60 | 開始承保 | →購買 |
11/17/2020 | 1421.7% | 康託·菲茨傑拉德 | $60→$63 | 維護 | 超重 |
09/17/2020 | 1349.24% | 康託·菲茨傑拉德 | $59→$60 | 維護 | 超重 |
08/04/2020 | 606.5% | 李約瑟 | $18.2→$29.25 | 維護 | 買 |
06/30/2020 | 1156.01% | 康託·菲茨傑拉德 | $50→$52 | 維護 | 超重 |
2020/05/21 | 339.6% | 李約瑟 | $17.2→$18.2 | 維護 | 買 |
2020/05/13 | 315.45% | 李約瑟 | $15.5→$17.2 | 維護 | 買 |
04/09/2020 | 274.39% | 李約瑟 | $15.25→$15.5 | 維護 | 買 |
04/06/2020 | 624.62% | 康託·菲茨傑拉德 | $32→$30 | 維護 | 超重 |
03/23/2020 | 268.35% | 李約瑟 | $20→$15.25 | 維護 | 買 |
02/14/2020 | 624.62% | 康託·菲茨傑拉德 | →$30 | 開始承保 | →超重 |
2019年12月16日 | 383.08% | 克雷格-哈勒姆 | →$20 | 開始承保 | →購買 |
2019/12/03 | 383.08% | 李約瑟 | →$20 | 開始承保 | →購買 |
2019年2月12日 | 310.62% | 指南針 | $11→$17 | 升級 | 中性→購買 |
What is the target price for Trulieve Cannabis (TCNNF)?
Trulieve Cannabis的目標價格是多少?
The latest price target for Trulieve Cannabis (OTCQX: TCNNF) was reported by Wedbush on August 11, 2023. The analyst firm set a price target for $6.00 expecting TCNNF to rise to within 12 months (a possible 44.92% upside). 8 analyst firms have reported ratings in the last year.
韋德布什於2023年8月11日報道了Trulieve Cannabis(OTCQX:TCNNF)的最新目標價。這家分析公司將目標價定為6美元,預計TCNNF將在12個月內上漲至44.92%(可能上漲44.92%)。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for Trulieve Cannabis (TCNNF)?
Trulieve Cannabis(TCNNF)的最新分析師評級是多少?
The latest analyst rating for Trulieve Cannabis (OTCQX: TCNNF) was provided by Wedbush, and Trulieve Cannabis maintained their outperform rating.
韋德布什提供了對Trulieve Cannabis(場外交易市場代碼:TCNNF)的最新分析師評級,Trulieve Cannabis維持了其表現優於大盤的評級。
When is the next analyst rating going to be posted or updated for Trulieve Cannabis (TCNNF)?
Trulieve Cannabis(TCNNF)的下一次分析師評級將於何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Trulieve Cannabis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Trulieve Cannabis was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與Trulieve Cannabis的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Trulieve大麻的上一次評級是在2023年8月11日提交的,所以你應該預計下一次評級將在2024年8月11日左右提供。
Is the Analyst Rating Trulieve Cannabis (TCNNF) correct?
分析師評級Trulieve Cannabis(TCNNF)正確嗎?
While ratings are subjective and will change, the latest Trulieve Cannabis (TCNNF) rating was a maintained with a price target of $8.00 to $6.00. The current price Trulieve Cannabis (TCNNF) is trading at is $4.14, which is out of the analyst's predicted range.
雖然評級是主觀的,並將發生變化,但最新的Trulieve Cannabis(TCNNF)評級維持不變,目標價在8.00美元至6.00美元之間。Trulieve Cannabis(TCNNF)目前的交易價格為4.14美元,超出了分析師的預測區間。